University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 19 of 27
Fatigue Reduction Diet
NCT01902745
Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms
NCT01983982
What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
NCT01992718
Achieving Better Control for Older Adults With Asthma
NCT01979055
Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
NCT01983995
Effect of Exercise on Metabolic Health
NCT02001142
Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
NCT02058732
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
NCT01920243
Neuronal Responses to Social Feedback in Major Depressive Disorder
NCT02180607
Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))
NCT01993108
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713
Novel Screening Strategies for Scleroderma PAH
NCT01959815
Imaging Biomarkers for TMS Treatment of Depression
NCT01900314
Motivational Interviewing to Increase Parent Engagement in Preventive Parenting Programming
NCT01955551
Telemonitoring Enhanced Support for Depression Self Management
NCT01834534
Acupressure for Knee Pain in Older Adults
NCT02003443
Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
NCT02226666
Comparison of Two Topical Anesthetics: Benzocaine Versus Pliaglis
NCT01951820
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
NCT02151435
Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care
NCT01920256
Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program
NCT01923467
Fatty Acid Regulation of Platelet Function in Diabetes
NCT02373332
Amlexanox for Type 2 Diabetes and Obesity
NCT01842282
Maestro Handheld Cardiac Monitor Validation
NCT02977104
Impacts of Public Announcements of Goals and Outcomes on Goal Completion (Commit to Steps)
NCT01811407
Parents' Knowledge and Perception of Benefits and Risks Regarding Neonatal Circumcision
NCT01909609
Reconstructing Consciousness and Cognition
NCT01911195
3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts
NCT02046473
A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan
NCT01914679
Decision Support for Parents Receiving Information About Child's Rare Disease
NCT01875640
Effects of Fish Oil on the Colon Mucosa
NCT01860352
Acupressure for Fatigue and Low Back Pain
NCT02106741
Safety & Prevention Outcomes Study
NCT01894087
Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology
NCT02462434
Occupational Therapy-Delivered Cognitive Behavioral Therapy for Symptomatic Knee Osteoarthritis
NCT02498847
Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model
NCT01799226
Resin Infiltration to Arrest Early Tooth Decay
NCT01584024
A Phase I In-Vivo Peptide Applied in the Right Colon
NCT01722058
Seizure Prophylaxis in Aneurysm Repair
NCT01801072
Amyloid Beta and Cognition in Parkinson Disease
NCT01754168
Developing a COPD Case Finding Methodology for Primary Care
NCT01880177
Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease
NCT02007525
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
NCT01871246
A Difference-In-Differences Analysis of New Persistent Opioid Use After Surgery
NCT04805229
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
NCT01769560
Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke
NCT01829386
Ongoing Diabetes Self-Management Support in Church-Based Settings
NCT02066155
Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients
NCT01760044
Acupressure for the Treatment of Raynaud's Phenomenon
NCT01784354
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
NCT01625923
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.